{"database": "lobbying", "table": "lobbying_activities", "rows": [[2820487, "ca65d829-202a-4008-8d87-51e245b35075", "Q2", "GOVERNMENT COUNSEL, LLC", 401105070, "HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS)", 2022, "second_quarter", "MED", "S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2022-07-15T12:54:30-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2820487"], "units": {}, "query_ms": 10.436230804771185, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}